ArticleFrontiers in oncology2026
Menstrual, reproductive, and contraceptive factors associated with cervical cancer in women aged ≤35 years: an individually matched case-control study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to investigate the associations of menstrual, reproductive, and contraceptive characteristics with early-onset cervical cancer among women aged ≤35 years. Methods: A hospital-based, individually matched case-control study was conducted at West China Second University Hospital from January 2022 to December 2024. A total of 300 women aged ≤35 years and with histologically confirmed cervical cancer were individually matched 1:1 to 300 screening controls within 0.5 years of age and 7 days of recruitment. Menstrual, reproductive, and contraceptive histories accrued up to 90 days before the index data were collected through standardized interviews and medical record reviews. Separate exposure-specific conditional logistic regression models stratified by matched pair were adjusted for prespecified sociodemographic, behavioral, screening-related, infection-related, and current high-risk human papillomavirus (hrHPV) covariates. The model samples ranged from 189 to 277 matched pairs. Exploratory subgroup analyses assessed effect modification. Results: In the fully adjusted model, menstrual period duration was associated with early-onset cervical cancer, with evidence of nonlinearity ( Conclusions: Selected menstrual, reproductive, and contraceptive characteristics were associated with early-onset cervical cancer after adjustment for measured confounders and current hrHPV status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.